Get Nephrology Costs in China
Medically reviewed by
Gokhan Temiz
What's the cost for Nephrology procedures in China?
Nephrology treatment in China typically costs between $4,400 and $19,400. The total expense depends on the stage of kidney disease, the frequency of dialysis sessions, and the complexity of surgical interventions like robotic-assisted procedures. Patients choosing China for treatment can expect approximately 40-60% savings compared to the US.
Typical Nephrology Costs in China
- Basic check-up: $300 – $700
- Biochemical blood analysis: $100 – $160
- Scintigraphy: $150 – $900
- Dialysis: $200 – $400
- Nephrectomy: $9,500 – $15,500
- Urethroscopic lithotripsy: $2,200 – $4,400
- Nephrectomy with Da Vinci Robot: $14,000 – $23,000
- Pyeloplasty: $5,500 – $9,500
- Ureteroscopy with laser lithotripsy (kidney stone removal): $3,800 – $6,800
- Robotic radical nephrectomy: $17,500 – $27,000
Major nephrology centers are located in Beijing, Shanghai, and Sanhe. While Beijing and Shanghai host the most specialized private clinics, facilities in other regions may offer different pricing structures. You should consult with a specialist to get accurate pricing for your specific medical needs.
| China | Turkey | Austria | |
|---|---|---|---|
| Urethroscopic lithotripsy | ≈ $2,200 | from $7,500 | ≈ $3,200 |
| Ureteroscopy with laser lithotripsy (kidney stone removal) | ≈ $3,800 | from $7,500 | ≈ $4,800 |
| Therapeutic Apheresis | ≈ $900 | from $4,500 | ≈ $1,800 |
| Robotic radical nephrectomy | ≈ $17,500 | from $15,400 | ≈ $17,500 |
| Pyeloplasty | ≈ $5,500 | from $7,500 | ≈ $14,000 |
All Nephrology conditions
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Nephrology treatment upon arrival and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Nephrology treatment and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Nephrology treatment journey.
Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Nephrology Clinics in China: 5 Verified Options and Prices
Fuda Cancer Hospital
Shijiazhuang Hetaiheng Hospital
Top Nephrology centers in China
- Xiamen Humanity Hospital, China
- Yanda International Hospital, China
- Fuda Cancer Hospital, China
- Hainan Chengmei Hospital, China
- Shijiazhuang Hetaiheng Hospital, China
Our Trusted Doctors
View all Doctors
Liao Zhengyin
Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.
Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.
Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.
Zhang Yan Lin
Dr. Zhang Yan Lin is a national authority in nephrology at Xiamen Humanity Hospital. She previously practiced at the First Affiliated Hospital of Xiamen University. Dr. Zhang holds several leadership roles on national medical boards. She has published over 30 research papers, including six in SCI-indexed journals.
- Serves as Deputy Chairperson for the Asia-Pacific Academy of Medical and Biological Immunology.
- Treats complex conditions like IgA nephropathy, lupus nephritis, and diabetic kidney disease.
- Performs renal replacement therapies including hemodialysis and peritoneal dialysis.
- Acted as principal investigator for multiple national and municipal scientific research projects.
Fan Yu
Dr. Fan Yu is the Director of Kidney Transplantation at Xiamen Humanity Hospital. He led a team that completed 112 kidney transplants within two years. His center has ranked first in Fujian Province for transplant volume three years running. Dr. Yu pioneered the diagnosis of chronic and subclinical rejection in China.
- Completed over 110 successful kidney transplants and one combined liver–kidney procedure.
- Served as Director or Deputy Director at major Shanghai transplant centers.
- Vice Chairman of the Transplant Surgeon Branch of the Chinese Medical Doctor Association.
- Published over 30 SCI-indexed papers and led 10 national research grants.
Liang Xiaoxiao
Professor Liang Xiaoxiao is the Department Director and Chief Physician in Neurorehabilitation. She holds a master’s degree in neurology. She is skilled in neuromodulation for disorders of consciousness, cognition, and movement. Her focus includes cases from cerebrovascular disease, Parkinson’s disease, and related conditions. She also performs ultrasound-guided botulinum toxin injections for blepharospasm, hemifacial spasm, limb spasticity, sialorrhea, and neuralgia.
Accreditations and roles: Member of the Neurorehabilitation, Cognitive Disorder Rehabilitation, and Craniocerebral Trauma Rehabilitation Committees of the Chinese Association of Rehabilitation Medicine. Standing Member of the Cognitive Disorder Rehabilitation Committee of the Fujian Association of Rehabilitation Medicine. Vice Chair of the Dementia and Cognitive Disorder Committee of the Xiamen Preventive Medicine Association. Vice President of the Parkinson’s Disease and Movement Disorders Committee of the Xiamen Medical Doctor Association. Standing Member of the Neuromodulation Committee of the Xiamen Medical Doctor Association. Recipient of the Most Beautiful Physician of Xiamen City (2024).
Share this content
Video Stories from Bookimed Patients
Anna Leonova
FAQ about Nephrology in China
Where are the best hospitals for kidney disease located in China?
The best hospitals for kidney disease in China are concentrated in Beijing, Shanghai, Guangzhou, and Nanjing. Peking University First Hospital and Chinese PLA General Hospital are top-tier facilities for nephrology. These centers specialize in advanced dialysis, renal replacement therapies, and complex kidney transplant procedures.
- Top specialist: Dr. Zhang Yan Lin at Xiamen Humanity Hospital has 30+ years experience.
- Leading center: Chinese PLA General Hospital is known for high-volume, complex kidney transplants.
- Beijing hub: Peking University First Hospital consistently ranks first nationally for nephrology research.
- Accreditation: Yanda International Hospital holds JCI accreditation and combines international and traditional protocols.
Bookimed Expert Insight: Data shows that Class A Level III clinics like Yanda International Hospital and Xiamen Humanity Hospital serve over 1,000,000 patients annually. These high-volume centers often house specialized departments for immunoadsorption and cell therapy. Choosing a facility with both academic research and high surgical volumes translates to better outcomes for chronic renal failure.
Patient Consensus: Patients note it is important to target triple-A hospitals in Beijing or Shanghai for the most serious cases. Many suggest bringing translated medical records to help doctors avoid errors during the initial consultation.
What are the primary challenges for dialysis patients in China?
Primary challenges for dialysis patients in China include significant regional service gaps and financial burdens. High out-of-pocket costs and reimbursement limits often restrict treatment frequency. Patients in rural areas face infrastructure barriers. Access for non-residents is limited without a local ID or specific insurance.
- Regional inequity: Treatment access is higher in eastern provinces than northwestern regions.
- Financial strain: Insurance often covers only two sessions weekly instead of three.
- Quality variance: Dialysis adequacy rates are 3x higher in developed provinces like Zhejiang.
- Facility congestion: Major city hospitals often run 12-hour shifts due to high demand.
- Access barriers: Non-locals and internal migrants struggle to register for regular sessions.
Bookimed Expert Insight: High-volume centers like Yanda International Hospital serve 2.5 million patients annually. These facilities often combine international protocols with traditional Chinese approaches. Patients should prioritize JCI-accredited centers in Beijing or Guangzhou to ensure consistent hygiene standards. These top-tier hospitals typically offer more stable session slots than smaller regional clinics.
Patient Consensus: Patients note that securing a hospital spot early through social media groups is essential. Many worry about the long travel times from rural areas to reach urban centers for reliable care.
What is the waiting period for a kidney transplant in China?
The average waiting period for a kidney transplant in China is approximately 3 to 4 years for domestic patients. Wait times vary significantly between hospitals and specific medical needs. International patients generally cannot join national waiting lists and must typically rely on a living relative donor.
- Wait time range: Domestic patients typically wait between 2 and 4.5 years for a match.
- Donor regulations: Official systems prioritize local citizens over international patients for deceased donor organs.
- Alternative treatments: Facilities like Xiamen Humanity Hospital offer dialysis for those managing long-term renal failure.
- Clinical expertise: Specialists like Dr. Zhang Yan Lin provide 30+ years of experience in nephrology.
Bookimed Expert Insight: While large centers like Yanda International Hospital serve 2,500,000 patients annually, they primarily focus on complex rehabilitation rather than transplant logistics. Patients seeking renal care should note that Class A Level III clinics offer the highest standards for long-term dialysis while navigating the transplant process.
Patient Consensus: Local residents note that waiting times on dialysis can vary based on financial resources and hospital location. Many emphasize the importance of verifying donor information independently and planning for long-term post-operative monitoring after returning home.
Are kidney transplant outcomes in China comparable to other countries?
China reports kidney transplant survival rates comparable to international benchmarks. The 1-year recipient survival for deceased donor transplants is approximately 97.8%. Living-related donor cases reach nearly 99.4% survival. These figures meet or exceed averages found in the United States and Europe.
- Survival rates: 1-year graft survival for deceased donors is roughly 95.7% in China.
- Clinical volume: Yanda International Hospital serves 2,500,000 patients annually as a Class A clinic.
- Expert oversight: Dr. Zhang Yan Lin has 30+ years of experience in renal replacement therapies.
- Wait times: Shorter cold ischemia times averaging 6 hours improve early graft function results.
- Graft longevity: China reports 3-year graft survival of 93.3% for deceased donor transplants.
Bookimed Expert Insight: High-volume centers like Yanda International Hospital and Xiamen Humanity Hospital manage over 1,000,000 patients annually each. This massive surgical volume often leads to highly refined perioperative protocols. Large-scale clinical trial capacity at Xiamen Humanity Hospital further suggests a strong integration of new pharmacological standards.
Patient Consensus: While short-term outcomes at top hospitals match international standards, patients emphasize the need for strict long-term follow-up care. Some note that maintaining stable health requires consistent access to regulated immunosuppressant medications after returning home.